上海百心安生物技术股份有限公司（股票代码：02185）于2026年4月8日发布2026年3月股份变动月报表，报告期为2026年3月。
根据公告，截至2026年3月31日，公司法定注册股本由235,703,422股H股和7,713,678股非上市外资股组成，面值均为人民币1元，合计243,417,100股。报告期内，公司无新增发行、无购回及注销，也未发生任何库存股变动。
此外，公告显示，公司本月无股份期权或股权激励计划的授出或行使记录，也未披露任何额外购回或注销信息。公司确认，截至本月底，各类股份仍符合香港联交所上市规则相关的公众持股量要求。
上述月报表由执行董事兼联席公司秘书王云磬签署。公司称将继续遵守香港联交所《上市规则》等相关法律法规，维护股东权益并保持股本结构的透明与稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.